Inmagene Biopharmaceuticals Funding: $40M Raised, Series B
Inmagene Biopharmaceuticals is based in San Diego, California. It has raised $40M in total funding. Latest round: Series B.
Inmagene Biopharmaceuticals funding overview
Inmagene Biopharmaceuticals is based in San Diego, California. Inmagene Biopharmaceuticals has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in November 2020. The round record for Inmagene Biopharmaceuticals runs through 2020; nothing later has been disclosed. Investors on record include Vertex Ventures China, Panacea Venture, Kunlun Capital, SCVC. 4 distinct backers are named across the disclosed rounds.
Frequently asked about Inmagene Biopharmaceuticals funding
How much has Inmagene Biopharmaceuticals raised?
Inmagene Biopharmaceuticals has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Inmagene Biopharmaceuticals?
Vertex Ventures China, Panacea Venture, Kunlun Capital, SCVC are named among the investors backing Inmagene Biopharmaceuticals.
What was the latest Inmagene Biopharmaceuticals funding round?
The most recent disclosed round is a Series B, announced in November 2020.
Where is Inmagene Biopharmaceuticals based?
Inmagene Biopharmaceuticals is based in San Diego, California.
When did Inmagene Biopharmaceuticals last raise?
The last disclosed Inmagene Biopharmaceuticals round closed in November 2020 at Series B.
We update the Inmagene Biopharmaceuticals record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in San Diego and their backers are listed below.
Companies related to Inmagene Biopharmaceuticals (22)
